Delivery Order SPE2DR25D3013-SPE2DR26F6T5S
Award Date 12/1/25
Potential Completion Date 12/22/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,218.46 to AmerisourceBergen Drug Corp for LUMAKRAS 320 mg tablets (90-count units) on November 28, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The contract is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,491.97 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of LUMAKRAS 320 mg tablets (90-unit quantity). This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, with performance to be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LUMAKRAS 320 mg tablets (90-count) with a ceiling value of $13,491.97. This firm fixed-price contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a firm fixed price of $13,491.97 and a performance period through June 30, 2025. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Lorbrena 100 mg tablets (30-count units) with a ceiling value of $23,248.72. This firm fixed-price delivery order is scheduled for completion by July 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction, reflecting...
- The Defense Logistics Agency awarded a $12.4K delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Lazcluze 80 mg tablets, with an ultimate completion date of June 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- This delivery order, awarded on September 24, 2025, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, provides for the supply of Lazcluze 240 mg tablets (30-count units) to support federal medical procurement needs. The $12,446.16 firm fixed-price order is funded by the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of October 16, 2025. The contract represents a non-competitive, competitively...
- The Defense Logistics Agency awarded a delivery order valued at $12,446.16 to AmerisourceBergen Drug Corp for the supply of Lazcluze 240 mg tablets (30-count units) on July 16, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,049.52 delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Lazanda 240 mg on October 29, 2025, with completion scheduled for November 20, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $24,500.52 to AmerisourceBergen Drug Corp for the supply of Lorbrena 25 mg tablets (30 count) under a firm fixed-price contract. The award was announced on November 13, 2025, with an ultimate completion date of December 5, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...